Form 4: Arteris CFO Sells Shares for Tax Obligations and Under Pre-Arranged Trading Plan

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, reported the sale of 8,837 shares of common stock in early July 2025, primarily to cover tax obligations from restricted stock units and through a pre-established 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc. (AIP), reported multiple sales of common stock.
• On July 2, 2025, a total of 3,889 shares were sold at a price of $8.9924 per share.
• These sales on July 2, 2025, were conducted to satisfy the reporting person's tax liability arising from the release of restricted stock units.
• On July 7, 2025, an additional 4,948 shares were sold at a weighted average price of $9.2207 per share.
• The sales on July 7, 2025, were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hawkins on May 20, 2024.
• The shares sold on July 7, 2025, were transacted at prices ranging from $9.00 to $9.35, inclusive.
• Following these transactions, Nicholas B. Hawkins beneficially owns 130,548 shares of Arteris, Inc. common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider sales can sometimes be a negative signal, the explicit reasons provided (tax liability and pre-arranged 10b5-1 plan) mitigate concerns about a lack of confidence in the company's future. These are common and often expected transactions for executives.

Positives

• The sales include transactions made under a Rule 10b5-1 trading plan, which indicates pre-planned sales and can mitigate concerns about opportunistic insider selling.
• A portion of the sales was explicitly for satisfying tax liabilities related to restricted stock units, a common and expected reason for insider stock sales.

Negatives

• The aggregate sale of 8,837 shares by a key executive like the CFO could be perceived negatively by some investors, as it reduces insider ownership.

Risks

• Insider selling, even for explained reasons, can sometimes lead to negative market sentiment or speculation, potentially impacting the stock price.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.
• Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on May 20, 2024.

Industry Context

This Form 4 filing is specific to an insider transaction at Arteris, Inc. and does not provide information relevant to broader industry trends or competitive landscape analysis.

Stakeholder Impact

• Shareholders may observe the reduction in insider ownership, though the stated reasons for the sales (tax obligations and 10b5-1 plan) are generally considered routine and less indicative of a negative outlook than discretionary sales.

Next Steps

• The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

Key Dates

Recommendation

Keywords

Arteris, AIP, Form 4, insider trading, stock sale, beneficial ownership, Nicholas B. Hawkins, 10b5-1 plan, restricted stock units, CFO